Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares, at a price of approximately HK$72.88 per share.
After the increase, the latest number of shares held is 15.096 million shares, and the latest shareholding ratio is 5.05%.
According to the latest data from the Hong Kong Stock Exchange, on July 30, Orient Holdings Limited (DFZQ) increased its stake in KEYMED BIO-B (02162) by 203,500 shares at a price of HKD 72.8753 per share, for a total amount of approximately HKD 14.8301 million. After the increase, the total number of shares held is 15.096 million, with the latest shareholding ratio at 5.05%.
Related Articles
Yushujing Technology (688836.SH) IPO Heat and the Noise: The Dark Pool Trading Rumors Are Groundless, and the Risks Behind Should Not Be Underestimated.
DAMAI ENT (01060) launches the "Good Luck Continuous" brand's plan for eight stores in six cities.
Three senior professionals joined the independent director lineup, and FU SHOU YUAN (01448) has a clearer path to resumption.
Yushujing Technology (688836.SH) IPO Heat and the Noise: The Dark Pool Trading Rumors Are Groundless, and the Risks Behind Should Not Be Underestimated.
DAMAI ENT (01060) launches the "Good Luck Continuous" brand's plan for eight stores in six cities.
Three senior professionals joined the independent director lineup, and FU SHOU YUAN (01448) has a clearer path to resumption.
RECOMMEND
